Death (any cause) · patients with diarrhoea due to Shiga toxin‐producing E. coli
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · paediatric patients with diarrhoea due to Shiga toxin‐producing E. coli
It is very uncertain whether urtoxazumab (3.0 mg/kg) changes death (any cause) compared with placebo (very low certainty).
1 finding from 1 review
Death (any cause) · paediatric patients with diarrhoea due to Shiga toxin‐producing E. coli
It is very uncertain whether urtoxazumab (1.0 mg/kg) changes death (any cause) compared with placebo (very low certainty).
1 finding from 1 review
Death (any cause) · patients with diarrhoea due to Shiga toxin‐producing E. coli
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
New diagnosis of dementia (at any time point after randomisation) Not measured
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Duration of delirium (days) (any time during hospital admission)
1 finding from 1 review
Intervention not reported
Delirium severity (any time during hospital admission) validated diagnostic instruments6 147 participants (5 studies)
1 finding from 1 review
Death from any cause at day 28 of · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause at day 28 of · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause at day 28 of · AKI patients receiving CKRT
It is very uncertain whether long (> 20 cm) changes death from any cause at day 28 of compared with short (≤ 20 cm) catheter (very low certainty).
1 finding from 1 review
Death from any cause · AKI patients receiving CKRT
It is very uncertain whether CVVHD changes death from any cause compared with CVVH or CVVHDF (very low certainty).
1 finding from 1 review
Death from any cause at day 28 of · AKI patients receiving CKRT
It is very uncertain whether surface‐modified changes death from any cause at day 28 of compared with standard double‐lumen catheter with identical geometry and flow design (very low certainty).
1 finding from 1 review
Death from any cause at day 28 of · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause at day 28 of · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause at day 28 of · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death from any cause at day 28 of · AKI patients receiving CKRT
It is very uncertain whether CVVHDF changes death from any cause at day 28 of compared with CVVH (very low certainty).
1 finding from 1 review
Self- or observational assessment of intraoperative distress/pain/acceptance of treatment during provision of LA: pain-related behaviour (any disruptive behaviour/sudden reaction/movement) · Children and adolescents having dental treatment under local anaesthetic without general anaesthesia
1 finding from 1 review
pain-related behaviour (any disruptive behaviour/sudden reaction/movement); 4 studies reported a benefit in using the wand while the remaining studies results suggested no difference between the 2 methods of delivering…
6 studies · 704 participants
Very low
Relapse · adults with renal vasculitis
Mycophenolate mofetil showed no clear difference in relapse at any time point compared with cyclophosphamide (low certainty).
1 finding from 1 review
Reduction in physical signs (number of patients without any conversive attacks in last 2 weeks) End of treatment · people with conversion disorder according to DSM‐IV or ICD‐10 criteria
It is very uncertain whether paradoxical intention therapy changes reduction in physical signs (number of patients without any… compared with diazepam (very low certainty).
1 finding from 1 review
Duration of any breastfeeding · postpartum breastfeeding women
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found